Intranasal insulin for improving cognitive function in multiple sclerosis
Cognitive impairment is common in people with multiple sclerosis (PwMS). There is an urgent need to identify/develop novel therapies that can help cognitive function in MS. Insulin is critical for helping with regulation of multiple CNS functions, including learning and memory. Insulin administrated...
Saved in:
| Main Authors: | Scott D. Newsome, Kathryn C. Fitzgerald, Abbey Hughes, Meghan Beier, Jacqueline Koshorek, Yujie Wang, Daniela Pimentel Maldonado, Thomas Shoemaker, Taimur Malik, Tarik Bayu, Pablo E. Ravenna, Ama Avornu, Elias S. Sotirchos, Meghan Romba, John Muschelli, Todd T. Brown, Peter A. Calabresi, Ellen M. Mowry |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Neurotherapeutics |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1878747925000595 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The subtle nuances of intranasal corticosteroids
by: James Fowler, et al.
Published: (2021-03-01) -
Study of embryotoxic effects of intranasally administred desloratadine on laboratory animals
by: Alekhina Т.А., et al.
Published: (2017-04-01) -
Study of embryotoxic effects of intranasally administred desloratadine on laboratory animals.
by: Т. А. Alekhina, et al.
Published: (2017-04-01) -
Marketing research on intranasal medicines of domestic market
by: B. S. Burlaka, et al.
Published: (2016-12-01) -
A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children
by: Anna Nikula, et al.
Published: (2024-03-01)